Home Cart 0 Sign in  

[ CAS No. 120221-14-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 120221-14-9
Chemical Structure| 120221-14-9
Structure of 120221-14-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 120221-14-9 ]

Related Doc. of [ 120221-14-9 ]

Alternatived Products of [ 120221-14-9 ]

Product Details of [ 120221-14-9 ]

CAS No. :120221-14-9 MDL No. :MFCD00037475
Formula : C12H14ClNO8 Boiling Point : -
Linear Structure Formula :- InChI Key :PJCVBKZRKNFZOD-RMPHRYRLSA-N
M.W : 335.69 Pubchem ID :18651654
Synonyms :

Calculated chemistry of [ 120221-14-9 ]

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.5
Num. rotatable bonds : 4
Num. H-bond acceptors : 8.0
Num. H-bond donors : 4.0
Molar Refractivity : 74.42
TPSA : 145.2 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.1
Log Po/w (XLOGP3) : 0.12
Log Po/w (WLOGP) : -0.57
Log Po/w (MLOGP) : -1.32
Log Po/w (SILICOS-IT) : -2.22
Consensus Log Po/w : -0.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.93
Solubility : 3.9 mg/ml ; 0.0116 mol/l
Class : Very soluble
Log S (Ali) : -2.72
Solubility : 0.632 mg/ml ; 0.00188 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.18
Solubility : 219.0 mg/ml ; 0.653 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 4.21

Safety of [ 120221-14-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 120221-14-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 120221-14-9 ]

[ 120221-14-9 ] Synthesis Path-Downstream   1~48

  • 1
  • [ 1263-76-9 ]
  • [ 120221-14-9 ]
  • [ 145072-72-6 ]
  • o-chloro-p-nitrophenyl 31-O-maltotriosyl-β-D-glucopyranoside [ No CAS ]
  • 2
  • [ 99304-80-0 ]
  • [ 143206-27-3 ]
  • [ 120221-14-9 ]
  • (2R,3R,4S,5S,6R)-2-{(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6S)-6-(2-Chloro-4-nitro-phenoxy)-4,5-dihydroxy-2-hydroxymethyl-tetrahydro-pyran-3-yloxy]-4,5-dihydroxy-2-hydroxymethyl-tetrahydro-pyran-3-yloxy}-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol [ No CAS ]
  • 3
  • [ 145072-72-6 ]
  • [ 143206-27-3 ]
  • [ 120221-14-9 ]
  • (2R,3R,4S,5S,6R)-2-{(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6S)-6-(2-Chloro-4-nitro-phenoxy)-4,5-dihydroxy-2-hydroxymethyl-tetrahydro-pyran-3-yloxy]-4,5-dihydroxy-2-hydroxymethyl-tetrahydro-pyran-3-yloxy}-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol [ No CAS ]
  • 4
  • [ 120221-14-9 ]
  • [ 2280-44-6 ]
  • [ 619-08-9 ]
  • 6
  • [ 35023-71-3 ]
  • [ 120221-14-9 ]
YieldReaction ConditionsOperation in experiment
40% With ammonia; In methanol; at 20.0℃; General procedure: Typically, the peracetylated aryl glycopyranosides 12 were suspended in 12-15mL 7M ammonia in methanol and stirred at ambient temperature. After 5-24h, all volatile material was evaporated. The resulting residue was recrystallized from ethyl acetate or purified by column chromatography on silica gel as noted yielding the target compounds [26].
  • 7
  • [ 120221-14-9 ]
  • [ 1397274-82-6 ]
  • 8
  • [ 120221-14-9 ]
  • [ 1397274-87-1 ]
  • 9
  • [ 120221-14-9 ]
  • [ 1397274-88-2 ]
  • 10
  • [ 120221-14-9 ]
  • [ 1397274-89-3 ]
  • 11
  • [ 120221-14-9 ]
  • [ 1397274-90-6 ]
  • 12
  • [ 120221-14-9 ]
  • [ 1397274-83-7 ]
  • 13
  • [ 120221-14-9 ]
  • C33H24ClNO11 [ No CAS ]
  • 14
  • [ 58479-61-1 ]
  • [ 120221-14-9 ]
  • [ 1397274-86-0 ]
  • 16
  • [ 120221-14-9 ]
  • [ 492-62-6 ]
  • 17
  • [ 120221-14-9 ]
  • 2'-chloro-4'-nitrophenyl 3-O-acetyl-2-O-benzoyl-β-D-allopyranoside [ No CAS ]
  • 18
  • [ 120221-14-9 ]
  • 2'-chloro-4'-nitrophenyl 2-benzoyl-4,6-benzylidene-β-D-glucopyranoside [ No CAS ]
  • 19
  • [ 120221-14-9 ]
  • 2'-chloro-4'-nitrophenyl 2-O-benzoyl-4,6-benzylidene-3-O-triflyl-β-D-glucopyranoside [ No CAS ]
  • 20
  • [ 120221-14-9 ]
  • 2'-chloro-4'-nitrophenyl 3-O-acetyl-2-O-benzoyl-4,6-benzylidene-β-D-allopyranoside [ No CAS ]
  • 21
  • [ 534-15-6 ]
  • [ 120221-14-9 ]
  • 2'-chloro-4'-nitrophenyl 4,6-benzylidene-β-D-glucopyranoside [ No CAS ]
YieldReaction ConditionsOperation in experiment
With camphor-10-sulfonic acid; at 20.0℃; for 2.0h; The synthesis was performed according to a general protocol for related compounds [56]. Benzaldehyde dimethyl acetal (0.43g, 2.799mmol, 1.25equiv.) and camphorsulfonic acid (0.10g, 0.431mmol, 0.14equiv.) were added to the solution of 11f (0.75g, 2.239mmol) in 15mL acetonitrile at ambient temperature. After 2h, the solution was neutralized with 0.3mL trimethylamine, concentrated to yield a residue that was purified by column chromatography over silica gel (hexane/ethyl acetate=4/1-1/1, v/v) to give 17 (0.82g, 1.953mmol, 87%) as a colorless solid; Rf 0.17 (SiO2, cyclohexane/ethyl acetate=2/1, v/v); mp 222-224C; deltaH (CD3OD) 8.33 (d, 2.8, 1H), 8.20 (dd, 9.0, 2.8, 1H), 7.49-7.56 (m, 2H), 7.46 (d, 9.3, 1H), 7.31-7.40 (m, 2H), 5.62 (s, 1H), 5.34 (d, 7.8, 1H), 4.33 (dd, 9.8, 4.5, 1H), 3.66-3.84 (m, 4H), 3.61 (t, 9.2, 1H); deltaC (CD3OD) 159.1, 143.8, 139.0, 130.0, 129.1, 127.5, 126.8, 124.9, 124.9, 116.8, 103.0, 102.1, 81.7, 75.4, 74.7, 69.4, 67.9; HRMS, ESI-TOF+ m/z calcd. for C19H18ClNNaO8 [M+Na]+: 446.0619; found 446.0622.
  • 22
  • C16H22O11*BrH [ No CAS ]
  • [ 120221-14-9 ]
  • 25
  • [ 58880-19-6 ]
  • [ 120221-14-9 ]
  • trichostatin C [ No CAS ]
  • 26
  • [ 120221-14-9 ]
  • [ 208260-29-1 ]
  • C29H33N3O8 [ No CAS ]
  • 27
  • [ 120221-14-9 ]
  • tilmicosin [ No CAS ]
  • C52H90N2O18 [ No CAS ]
  • 28
  • [ 50-53-3 ]
  • [ 120221-14-9 ]
  • 3’-N-(β-D-glucopyranosyl)chlorpromazine [ No CAS ]
  • 29
  • [ 90-33-5 ]
  • [ 120221-14-9 ]
  • [ 18997-57-4 ]
  • 30
  • [ 303-49-1 ]
  • [ 120221-14-9 ]
  • 3’-N-(β-D-glucopyranosyl)clomipramine [ No CAS ]
  • 31
  • [ 303-53-7 ]
  • [ 120221-14-9 ]
  • C26H32NO5(1+) [ No CAS ]
  • 32
  • [ 146-54-3 ]
  • [ 120221-14-9 ]
  • C24H30F3N2O5S(1+) [ No CAS ]
  • 33
  • [ 50-49-7 ]
  • [ 120221-14-9 ]
  • C25H35N2O5(1+) [ No CAS ]
  • 34
  • [ 50-48-6 ]
  • [ 120221-14-9 ]
  • C26H34NO5(1+) [ No CAS ]
  • 35
  • [ 1668-19-5 ]
  • [ 120221-14-9 ]
  • C25H32NO6(1+) [ No CAS ]
  • 36
  • [ 120221-14-9 ]
  • [ 619-08-9 ]
  • 37
  • [ 72-48-0 ]
  • [ 120221-14-9 ]
  • [ 31297-82-2 ]
  • 38
  • [ 518-82-1 ]
  • [ 120221-14-9 ]
  • [ 34298-85-6 ]
  • 39
  • [ 117-39-5 ]
  • [ 120221-14-9 ]
  • [ 482-35-9 ]
  • 40
  • L-digitoxosyl-phenanthroviridin [ No CAS ]
  • [ 120221-14-9 ]
  • C30H31NO12 [ No CAS ]
  • 41
  • [ 21802-37-9 ]
  • [ 120221-14-9 ]
  • C18H21N3O7 [ No CAS ]
  • 42
  • [ 72956-09-3 ]
  • [ 120221-14-9 ]
  • C30H36N2O9 [ No CAS ]
  • 43
  • [ 120221-14-9 ]
  • 2-chloro-4-nitrophenyl β-D-glucuronide [ No CAS ]
  • 44
  • [ 120221-14-9 ]
  • dacinostat [ No CAS ]
  • C28H35N3O8 [ No CAS ]
  • 45
  • [ 497833-27-9 ]
  • [ 120221-14-9 ]
  • C30H37N3O9 [ No CAS ]
  • 46
  • [ 922726-10-1 ]
  • [ 120221-14-9 ]
  • C27H33N3O7 [ No CAS ]
  • 47
  • [ 1252003-15-8 ]
  • [ 120221-14-9 ]
  • C26H31N3O7 [ No CAS ]
  • 48
  • abexinostat [ No CAS ]
  • [ 120221-14-9 ]
  • C27H33N3O10 [ No CAS ]
Same Skeleton Products
Historical Records